Blog - Page 311 of 5630 - QualityStocks

TuesdayFeb 25, 2025 12:55 pm

QualityStocksNewsBreaks – Tuttle Capital Management Featured in Stock2Me Podcast

IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, has announced release of the latest episode of the Stock2Me Podcast as part of its sustained effort to provide specialized content distribution via widespread syndication channels. The program features Matthew Tuttle, CEO of Tuttle Capital Management, an investment firm focused on providing innovative strategies while challenging Wall Street's institutional biases. During the engaging conversation with IBN’s Jonathan Keim, Tuttle discusses the appeal of memecoins, excitement in the crypto community for the opportunity to trade beyond Bitcoin and Ether, and advances in artificial intelligence that are reshaping…

TuesdayFeb 25, 2025 11:52 am

QualityStocksNewsBreaks – Twin Hospitality Group Inc. (NASDAQ: TWNP) Completes Spinoff from FAT Brands Inc. (NASDAQ: FAT)

Twin Hospitality (NASDAQ: TWNP), the owner of the Twin Peaks and Smokey Bones restaurant brands, has completed its spinoff from FAT Brands (NASDAQ: FAT), a leading global franchising company and parent company of 18 iconic brands. In conjunction with the spin-off, Twin Hospitality Class A Common Stock began trading under the symbol TWNP on the Nasdaq Global Market. Roth Capital Partners acted as financial advisor for the transaction. For more information, visit https://ibn.fm/q7xjN About Twin Peaks Founded in 2005 in the Dallas suburb of Lewisville, Twin Peaks franchises and owns 115 restaurants in the United States and Mexico. Twin Peaks…

TuesdayFeb 25, 2025 11:30 am

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Drives Growth with Strengthened Financial Position and Cutting-Edge Research

One of the most significant challenges facing biotechnology companies is securing adequate funding to sustain research and development efforts. Calidi’s improved financial footing reassures investors and allows the company to focus on achieving key milestones in its research pipeline. The company has been selected to present new data on its RTNova systemic virotherapy platform at the prestigious AACR annual meeting in April 2025. Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company, is making significant strides in the field of cancer immunotherapy. Known for its innovative approach to antitumor virotherapies, Calidi is focused on harnessing the power of its patented…

TuesdayFeb 25, 2025 10:45 am

How Adageis Simplifies Value-Based Care, Boosting Revenue for Healthcare Providers

Adageis streamlines complex insurance contracts, helping providers maximize reimbursements. The company’s AI-driven solutions reduce administrative burden, freeing up time for patient care. Seamless integration with nearly 100 EHR systems ensures a smooth transition to value-based care models. The company’s fintech approach enhances financial performance, with providers seeing up to $75,000 in additional revenue. Adageis projects significant growth, expecting to cover 580,000 patient lives by mid-2025. Healthcare is shifting toward value-based care, where providers are reimbursed for patient outcomes rather than the number of procedures performed. While the model promises higher-quality care at lower costs, it also introduces complex reimbursement structures…

TuesdayFeb 25, 2025 10:00 am

East Coast Cannabis Industry Gets Ready for the New England Cannabis Convention in Boston

Traders, dealers, businesses, and enthusiasts of the cannabis industry are invited to attend the New England Cannabis Convention in Boston from March 21 to March 22, 2025. Operating since 2015, NECANN events are referred to as “MJBizCon East.” The second largest B2B event in the U.S., NECANN witnesses thousands of attendees, with the largest gathering of licensed operators, exhibitors, buyers, and leaders, for the East Coast cannabis market. These events are considered the home base for the Northeast cannabis industry. The Boston NECANN Convention 2025 will also host the prize-giving ceremony for the Boston NECANN Cup winners on March 22,…

TuesdayFeb 25, 2025 9:55 am

QualityStocksNewsBreaks – GivBux Inc. (GBUX) Approves Special Dividend Warrant Issuance

GivBux (OTC: GBUX) announced that its Board of Directors approved a special dividend for shareholders in the form of warrants, authorizing a 1-for-10 warrant issuance that will allow the purchase of additional common stock at a price to be determined later. The dividend underscores the company’s commitment to rewarding loyal shareholders and enabling participation in future growth as it scales its Super App platform globally, said President Umesh Tim Singh. Pricing details and the warrant exercise period will be provided in future communications. To view the full press release, visit https://ibn.fm/oB172 About GivBux Inc. The GivBux Super App revolutionizes shopping…

TuesdayFeb 25, 2025 9:30 am

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Partners with APST Research to Advance ALS Drug Approval Process

Clene (NASDAQ: CLNN) has entered into an agreement with Germany-based APST Research GmbH to utilize its extensive neurofilament light chain (NfL) database in FDA-recommended analyses of CNM-Au8® for treating amyotrophic lateral sclerosis (ALS). APST's repository includes biomarker data from over 4,300 ALS patients, which will help Clene compare NfL changes in NIH-sponsored Expanded Access Protocol participants to matched controls. The results could support Clene’s planned New Drug Application submission for CNM-Au8 under the FDA's Accelerated Approval pathway in the second half of 2025. CEO Rob Etherington emphasized the importance of leveraging real-world evidence to advance potential treatments for ALS. To view…

TuesdayFeb 25, 2025 9:20 am

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Expands Investment in Mozambican Football Club Black Bulls

Brera Holdings (NASDAQ: BREA) and Lalgy Transport have signed a Letter of Intent to expand their investment in Mozambique’s Black Bulls, the reigning Mocambola league champion. Under the agreement, Brera will become a co-owner of the club, reinforcing its mission to develop African football talent and create global pathways for players. The partnership will see Brera and Mr. Lalgy collaborate to enhance the competitiveness of Mozambican football, particularly in European markets. As part of this strategy, Brera Tchumene FC will pause its independent operations to align efforts with Black Bulls, optimizing resources for long-term growth. To view the full press…

MondayFeb 24, 2025 1:55 pm

QualityStocksNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), Viridi Collaborate on Hybrid Generation Solar Project in Buffalo

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), an independent renewable and clean energy project developer and owner focusing on distributed and community solar projects in Canada and the U.S., was featured in an article published by Buffalo Business First. The piece highlights SolarBank’s collaboration with Viridi on a proposed $7 billion solar project at a former landfill in South Buffalo, which would include 3.06 megawatts of solar generation and 1.2 megawatt-hours of battery storage. While relatively rare, these hybrid generation projects are becoming more common according to Matthew McGregor, senior developer of U.S.…

MondayFeb 24, 2025 1:00 pm

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Sees Growth, Potential in Oncology Drug Development, a Critical Frontier in Cancer Treatment

According to the American Cancer Society, cancer is the second leading cause of death globally. Oncology drugs are a cornerstone of modern cancer treatment. Calidi Biotherapeutics is a cutting-edge biotechnology company dedicated to developing innovative cancer treatments. Cancer continues to be one of the most significant health challenges of our time, with its global impact growing every year. The increasing number of cancer diagnoses and related deaths underscores the urgent need for more effective treatments, including advanced oncology drugs. Companies such as Calidi Biotherapeutics (NYSE American: CLDI) are at the forefront of research and development, offering hope for millions of…

Site Search

Company Search